Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for Esperion Therapeutics, Inc. (ESPR)

« Back to company index

ESPR Chatter Timeline

Stock Ticker for ESPR

Most Active Tweeters for ESPR

UserTweets
@Tickeron 11
@BlueBioNow 7
@gcassidy718 6
@QuantchaIdeas 4
@AmericanBanking 4

Recent Tweets for ESPR

HealthcareBeat @HealthcareBeat
A drug developer with a franchise pointing to 372% upside - Needham $ESPR https://t.co/2DazzhRAbD
7:08pm
egelandd @egelandd
@DeepSouthDoctor @bigpharmaguy ? $espr is stupid cheap here- a bio that actually makes money- novel concept I know-… https://t.co/LisrHx7OaD
4:08pm
bigpharmaguy @bigpharmaguy
@DeepSouthDoctor What impressed you on $ESPR? Did not read it but that sales # is puts a tight ceiling on any upside for a while IMO
3:08pm
glareone @glareone
$ESPR Daily chart ??? https://t.co/6CCvstCtLs
3:08pm
AmericanBanking @AmericanBanking
Esperion Therapeutics $ESPR Releases Earnings Results, Beats Estimates By $2.19 EPS https://t.co/ekTJ10i5G7 #stocks
1:08pm
mediasentiment @mediasentiment
$ESPR new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 2442
11:08am
AmericanBanking @AmericanBanking
Esperion Therapeutics $ESPR Given Buy Rating at Needham & Company LLC https://t.co/tKKQr2opRk #stocks
11:08am
haodongvli @haodongvli
$ESPR After 12 month of consolidation, with more than 4000 scripts in July, will get respects soon
10:08am
egelandd @egelandd
@Eminyel @haodongvli $espr is an amazing opp at these levels- stupid cheap- all in!
10:08am
deus_trader @deus_trader
Optimus v4 2020-08-11 09:40 ET. Bought/Opened: $ESPR at $32.75. Esperion Therapeutics, Inc (CORP). Win Chance: 76%… https://t.co/zztVqkWsS9
9:08am
deus_trader @deus_trader
Optimus v4 2020-08-11 09:35 ET. *Closed/Sold: $ESPR at $33.98 for 6.35 loss (-15.74%). Esperion Therapeutics, Inc (… https://t.co/bXhLkj2bvp
9:08am
dmbaldas @dmbaldas
$ESPR beats on earnings report * ESPERION REPORTS SECOND QUARTER 2020 FINANCIAL RESULTS * Q2 REVENUE $212.2 MILL… https://t.co/Zq3ZmJv5Yq
9:08am
Eminyel @Eminyel
Those analyst upgrades for $ESPR are coming
8:08am
HandyRandy05 @HandyRandy05
RT @AniuStudent: That’s a sexy graph. $ESPR
8:08am
HandyRandy05 @HandyRandy05
RT @StockPods: $ESPR Earnings Call Today: 4:30 PM EST Analyst Rating: Strong Buy Webcast: https://t.co/zzBqjzAc8u
8:08am
HandyRandy05 @HandyRandy05
RT @MarketCurrents: $ESPR - Esperion Therapeutics EPS beats by $2.09, beats on revenue https://t.co/X4JszPrV3S
8:08am
AmericanBanking @AmericanBanking
Esperion Therapeutics $ESPR Stock Rating Reaffirmed by Stifel Nicolaus https://t.co/Lm9UGlADKm #stocks
8:08am
HandyRandy05 @HandyRandy05
RT @WatchlistN: Esperion Therapeutics $ESPR Given Buy Rating at Needham & Company LLC https://t.co/6rrubBrnWu
8:08am
OpenOutcrier @OpenOutcrier
$ESPR (-1.9% pre) Esperion Reports Second Quarter 2020 Financial Results and Provides Company Update - GN https://t.co/vkgI72hni5
8:08am
pnani456 @pnani456
RT @semodough: CS $ESPR Esperion Therapeutics, Inc. [ESPR.OQ] Downgrade to Neutral: We Believe a Stronger Capital Position Is Needed to Sup…
7:08am
semodough @semodough
$ESPR Downgrade to Neutral; Lowering TP to $45. Our change in stance reflects limited visibility on more bullish 20… https://t.co/dcVBdDaMRO
6:08am
semodough @semodough
CS $ESPR Esperion Therapeutics, Inc. [ESPR.OQ] Downgrade to Neutral: We Believe a Stronger Capital Position Is Need… https://t.co/jsWcyeMLpP
6:08am
WatchlistN @WatchlistN
Esperion Therapeutics $ESPR Given Buy Rating at Needham & Company LLC https://t.co/6rrubBrnWu
6:08am
EarningsAlley @EarningsAlley
Esperion Therapeutics, Inc. $ESPR held an earnings call on 8/10/2020. Here are the highlights:
2:08am
ChartMill @ChartMill
$ESPR has a poor technical rating and the quality of the setup is also not perfect at the moment.… https://t.co/fCIZHZGNwh
2:08am
newsfilterio @newsfilterio
Esperion Reports Second Quarter 2020 Financial Results and Provides Company Update $ESPR https://t.co/vy8OaOmfrU
1:08am
Eminyel @Eminyel
@lblegend33 I’m praying ???? for $ESPR buyout
12:08am
SiteFocusHQ @SiteFocusHQ
$ESPR Earnings Intelligence Analysis of recent earnings identified ESPR business focus on (health,non-statin,once-d… https://t.co/ZhRFXZDVXI
12:08am
SeekingAlpha @SeekingAlpha
$ESPR - Esperion Therapeutics, Inc. (ESPR) CEO Tim Mayleben on Q2 2020 Results - Earnings Call Transcript.… https://t.co/VM4cOMjSNY
August 10th 2020, 11:08pm
newsfilterio @newsfilterio
Esperion Therapeutics EPS beats by $2.09, beats on revenue $ESPR https://t.co/m8hZ4MW2Wj
August 10th 2020, 10:08pm
HealthcareBeat @HealthcareBeat
Form 10-Q (quarterly report [sections 13 or 15(d)]) filed with the SEC $ESPR https://t.co/X7lEsg9m46
August 10th 2020, 10:08pm
egelandd @egelandd
$espr team is executing with excellence! Thx @haodongvli for the strong graphic of their performance! The current P… https://t.co/7NA0T4N5oj
August 10th 2020, 10:08pm
HealthcareBeat @HealthcareBeat
Form S-8 (securities to be offered to employees in employee benefit plans) filed with the SEC $ESPR https://t.co/INvRu2p2iK
August 10th 2020, 10:08pm
sbwcws @sbwcws
Esperion downgraded to Neutral from Outperform at Credit Suisse $ESPR
August 10th 2020, 9:08pm
Tickeron @Tickeron
$ESPR's Aroon indicator drops into Downtrend on August 7, 2020. View odds for this and other indicators:… https://t.co/TOgMU5Jju0
August 10th 2020, 8:08pm
EdgarInsider @EdgarInsider
A new filing Form 10-Q [Quarterly Report] has been made at the SEC by $ESPR #EsperionTherapeutics, Inc https://t.co/3FAOExKYMG
August 10th 2020, 6:08pm
AniuStudent @AniuStudent
That’s a sexy graph. $ESPR https://t.co/jnNhoDjqiW
August 10th 2020, 6:08pm
haodongvli @haodongvli
$ESPR in July, already beaten PCSK9 https://t.co/Z6UZ82mwj0
August 10th 2020, 6:08pm
pnani456 @pnani456
RT @Briefingcom: $ESPR: Esperion Therapeutics beats by $2.92, beats on revs https://t.co/uquNL4woEI
August 10th 2020, 6:08pm
Briefingcom @Briefingcom
$ESPR: Esperion Therapeutics beats by $2.92, beats on revs https://t.co/uquNL4woEI
August 10th 2020, 6:08pm
SeekingAlpha @SeekingAlpha
$ESPR - Esperion Therapeutics, Inc. 2020 Q2 - Results - Earnings Call Presentation. https://t.co/81GZlswTBW #business #investing #finance
August 10th 2020, 5:08pm
ConsumerFeed @ConsumerFeed
Esperion Therapeutics $ESPR to Release Quarterly Earnings on Monday https://t.co/6SX3I9DtWx
August 10th 2020, 5:08pm
mehabecapital @mehabecapital
(Earnings) Esperion Th( $ESPR ) Actual.EPS=4.32 vs Est.EPS=1.65, Actual.Rev=212.2M vs Est.Rev=147.97M https://t.co/hPfNFQrFpu
August 10th 2020, 5:08pm
sbwcws @sbwcws
Esperion sees further cash to be provided from U.S. product sales $ESPR
August 10th 2020, 4:08pm
fintel_io @fintel_io
$ESPR / Esperion Therapeutics files form 8-K - Financial Statements and Exhibits, Results of Operations and Financi… https://t.co/6cJy0gulrK
August 10th 2020, 4:08pm
tq_equities @tq_equities
$ESPR snaps to lowest close since April 16th: https://t.co/NzwTJlGOMZ Sentiment: Neutral #ESPR
August 10th 2020, 4:08pm
EdgarInsider @EdgarInsider
SEC Form 8-K [Press/News Current Report] filed by $ESPR #EsperionTherapeutics, Inc https://t.co/F0EDWS5pPQ
August 10th 2020, 4:08pm
MarketCurrents @MarketCurrents
$ESPR - Esperion Therapeutics EPS beats by $2.09, beats on revenue https://t.co/X4JszPrV3S
August 10th 2020, 4:08pm
MarcJacksonLA @MarcJacksonLA
$ESPR Esperion Reports Second Quarter 2020 Financial Results and Provides Company Update https://t.co/wRVzooq5Hx
August 10th 2020, 4:08pm
FlashAlert_me @FlashAlert_me
$ESPR [15s. delayed]: Issued Press Release on August 10, 16:04:00: Esperion Reports Second Quarter 2020 Financial R… https://t.co/yjZXNR2a8l
August 10th 2020, 4:08pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2020. All rights reserved.